Key result
Histology-driven adjuvant chemotherapy identifies soft tissue sarcoma patients with high metastatic potential who benefit from treatment.
Population
Patients with localized soft tissue sarcomas (STSs)
Design
Review
Authors
Loading...
Hypothesis-generating for histology-driven adjuvant chemotherapy in soft tissue sarcomas; prospective trials needed before changing practice.
This perspective emphasizes the need for histology-driven adjuvant chemotherapy in soft tissue sarcomas to maximize clinical benefit.
Bajpai et al. (2016) conducted a review in Soft tissue sarcomas (STSs). Adjuvant chemotherapy was evaluated. Adjuvant chemotherapy in soft tissue sarcomas requires a histology-driven approach to identify subpopulations with high metastatic potential who may benefit from treatment.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: